Atlas Trials

Long-term Safety and Tolerability of BHV-7000

Clinical trial NCT06443463 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06443463
Sponsor
Biohaven Therapeutics Ltd.
Status
ENROLLING_BY_INVITATION
Phase
Phase 2
Study type
INTERVENTIONAL
Focal Epilepsy
Start date
2024-07-30
Primary completion
2026-12-01
Enrollment
660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.